Affymetrix's Q3 Revenues Down 5 Percent on Service Business Decline | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A $5 million decline in service revenues was one of the reasons for a 5 percent drop in total revenues for Affymetrix during its third quarter, the company reported Wednesday after the close of the market.

For the three months ended Sept. 30, the Santa Clara, Calif.-based microarray firm reported total revenues of $74 million, down from $78.2 million a year ago, but still above analyst estimates of $73.3 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.